Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Income from Continuing Operations (2016 - 2025)

Rockwell Medical's Income from Continuing Operations history spans 16 years, with the latest figure at 640000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 17.84% year-over-year to 640000.0; the TTM value through Dec 2025 reached 5581000.0, down 907.4%, while the annual FY2025 figure was 5581000.0, 907.4% down from the prior year.
  • Income from Continuing Operations reached 640000.0 in Q4 2025 per RMTI's latest filing, up from 1814000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1664000.0 in Q3 2024 to a low of 8942000.0 in Q4 2021.
  • Average Income from Continuing Operations over 5 years is 3312700.0, with a median of 1953000.0 recorded in 2023.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 179.54% in 2024, then plummeted 632.88% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 8942000.0 in 2021, then surged by 73.59% to 2362000.0 in 2022, then skyrocketed by 31.71% to 1613000.0 in 2023, then surged by 51.7% to 779000.0 in 2024, then rose by 17.84% to 640000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Income from Continuing Operations are 640000.0 (Q4 2025), 1814000.0 (Q3 2025), and 1556000.0 (Q2 2025).